We are excited to be one of the first conferences to be held in the newly constructed Summit Convention Center in Seattle, Washington. As always, the best and most consequential original research will define the science at CROI, including research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. Research that has not been published or presented at a large HIV or SARS-CoV-2 conference prior to CROI will be eligible for inclusion at CROI, the world’s foremost conference of its kind.
The Conference on Retroviruses and Opportunistic Infections (CROI) was established in 1993 to provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases. The synergy of basic science and clinical investigation has been a major contributor to the success of the meeting. CROI has facilitated the presentation of important discoveries in the field, thereby accelerating progress in HIV and AIDS research. The best and most consequential original research defines the science at CROI, including research in HIV, hepatitis viruses, SARS-CoV-2, monkeypox, and other viral infections and their related conditions.
Abstracts are evaluated by the Scientific Program Committee and additional reviewers for the relevance of their topics, the rigor of their research, and the distinct contributions they make to the broad spectrum of study that CROI strives to provide each year.
Attendance at the conference is open to researchers and clinical educators actively involved in the study and management of HIV, other retroviruses, and related medical conditions. Limited space is also available to members of the media whose work aligns with the scientific and educational aims of the conference.
Important dates and deadlines
The 30th Conference on Retroviruses and Opportunistic Infections (CROI) will be held from February 19 to 22, 2023, and is currently planned as an in-person conference in Seattle, Washington, USA, with an option for virtual participation for most sessions.
Abstract Submission Deadlines
- The submission deadline for general abstracts on HIV and hepatitis viruses and their related conditions is September 20, 2022. Submission is set to open in late August
- The submission deadline for abstracts on all SARS-CoV-2 and monkeypox sciences plus late-breaking abstracts on HIV and hepatitis viruses is January 5, 2023. Data analyzed after the general abstract submission deadline should not be submitted as late-breaking research on HIV and hepatitis viruses and their related conditions unless they meet a high threshold of scientific merit